15 studies found for:
5-HT2A
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors
|
||||
| 2 | Completed |
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
|
||||
| 3 | Completed |
An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression
|
||||
| 4 | Completed |
SPECT Study With SB-773812 In Schizophrenic Patients
|
||||
| 5 | Completed |
A Dose-Ranging Study of JNJ-40411813 in Healthy Male Volunteers
|
||||
| 6 | Completed |
Trazodone for SSRI-sexual Dsyfunction
|
||||
| 7 | Completed |
Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging
|
||||
| 8 | Completed |
Predicting Medication Response in Obsessive Compulsive Disorder
|
||||
| 9 | Completed |
Dose-Finding Safety and Efficacy Trial in the Treatment of Vasomotor Symptoms (46101)(COMPLETED)
|
||||
| 10 | Completed |
ACP-103 to Treat Parkinson's Disease
|
||||
| 11 | Completed |
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
|
||||
| 12 | Not yet recruiting |
PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia
|
||||
| 13 | Completed |
Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
|
||||
| 14 | Unknown † |
A 4-Week, Randomized, Rater-Blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
|
||||
| 15 | Recruiting |
Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
|
† Indicates status has not been verified in more than two years